FoxO3a confers cetuximab resistance in RAS wild-type metastatic colorectal cancer through c-Myc

about

PLOD2 regulated by transcription factor FOXA1 promotes metastasis in NSCLC.Uncoupling FoxO3A mitochondrial and nuclear functions in cancer cells undergoing metabolic stress and chemotherapy.

P2860

Q46614822-C4430A64-A1B0-4AEC-887D-39858B98AA5E Q50315356-DAE07CEE-880C-4FF9-B4BB-E56B44C08134

P2860

FoxO3a confers cetuximab resistance in RAS wild-type metastatic colorectal cancer through c-Myc

Item

http://www.wikidata.org/entity/Q37697088

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

FoxO3a confers cetuximab resis ...... olorectal cancer through c-Myc

@en

FoxO3a confers cetuximab resis ...... lorectal cancer through c-Myc.

@nl

type

Item

label

FoxO3a confers cetuximab resis ...... olorectal cancer through c-Myc

@en

FoxO3a confers cetuximab resis ...... lorectal cancer through c-Myc.

@nl

prefLabel

FoxO3a confers cetuximab resis ...... olorectal cancer through c-Myc

@en

FoxO3a confers cetuximab resis ...... lorectal cancer through c-Myc.

@nl

P1476

FoxO3a confers cetuximab resis ...... olorectal cancer through c-Myc

@en

P2093

Hong Li

http://www.w3.org/2001/XMLSchema#string

Jiawen Tian

http://www.w3.org/2001/XMLSchema#string

Ke Peng

http://www.w3.org/2001/XMLSchema#string

Li Liang

http://www.w3.org/2001/XMLSchema#string

Mengzhou Guo

http://www.w3.org/2001/XMLSchema#string

Shan Yu

http://www.w3.org/2001/XMLSchema#string

Tianshu Liu

http://www.w3.org/2001/XMLSchema#string

Xiaojing Xu

http://www.w3.org/2001/XMLSchema#string

Yan Wang

http://www.w3.org/2001/XMLSchema#string

Ye Wei

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolic vulnerabilities of MYC-induced cancer

MYC, Metabolism, and Cancer

New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?

MYC and metabolism on the path to cancer

FOXO transcription factors throughout T cell biology

FOXOs and sirtuins in vascular growth, maintenance, and aging

Genetics of healthy aging and longevity

AMPK reverses the mesenchymal phenotype of cancer cells by targeting the Akt-MDM2-Foxo3a signaling axis.

FoxO3a and disease progression.

Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FOXM1 signaling cascade

P304

80888-80900

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.13105

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27825133

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

cetuximab

P932

5348362

http://www.w3.org/2001/XMLSchema#string

FoxO3a confers cetuximab resistance in RAS wild-type metastatic colorectal cancer through c-Myc

about

P2860

P2860

FoxO3a confers cetuximab resistance in RAS wild-type metastatic colorectal cancer through c-Myc

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932